triphenyltetrazolium has been researched along with contrast agent p792 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carme, S; Dewey, M; Farr, T; Hamm, B; Kaufels, N; Laule, M; Peukert, D; Schnorr, J; Schönenberger, E; Taupitz, M | 1 |
1 other study(ies) available for triphenyltetrazolium and contrast agent p792
| Article | Year |
|---|---|
Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
Topics: Animals; Contrast Media; Heterocyclic Compounds; Magnetic Resonance Imaging; Models, Animal; Myocardial Infarction; Myocardium; Organometallic Compounds; Perfusion; Swine; Tetrazolium Salts; Time Factors | 2007 |